Optical biosensors have exhibited worthwhile performance in detecting biological systems and promoting significant advances in clinical diagnostics, drug discovery, food process control, and environmental monitoring.
Evanescent wave (EW)-based optical biosensors have rapidly evolved into indispensable tools for real-time, non-invasive, and ultra-sensitive detection of biomolecular interactions. By enabling label-free analysis with unprecedented precision, they have significantly reshaped the landscape of clinical diagnostics and personalized medicine. In recent years, interdisciplinary innovations spanning materials science, nanotechnology, photonic integration, and microfluidics have propelled EW biosensors beyond their conventional roles, endowing them with capabilities that were once considered unattainable. This review aims to provide a comprehensive and up-to-date synthesis of recent advances in EW-based biosensing technologies, with a particular emphasis on their transformative applications in the medical field. Specifically, it seeks to critically evaluate the progress achieved across major biosensor platforms and to explore how these innovations are bridging the gap between fundamental research and clinical translation. The review systematically examines three representative EW biosensor platforms-surface plasmon resonance (SPR) sensors, silicon photonic sensors, and optical fiber sensors-highlighting their operating principles and recent breakthroughs. Innovations such as nanomaterial-enhanced sensitivity, chip-scale multiplexing, and portable point-of-care designs are pushing the boundaries of biosensing performance. Furthermore, emerging approaches, including seamless microfluidic integration and artificial intelligence-driven data interpretation, are recognized as essential for developing next-generation intelligent and autonomous biosensors. These advances collectively position EW biosensors to revolutionize precision diagnostics and enable real-time health monitoring, heralding a new era of biomedical science.
Cancer ranks as a leading cause of death and a huge obstacle to rising life expectancy. If cancers are spotted early there's a high chance of survival. The conventional methods relying on the phenotypic features of the tumor are not powerful to the early screening of cancer. Cancer biomarkers are capable of indicating specific cancer states. Current biochemical assay suffers from time and reagents consuming and discontinuous monitoring. Surface plasmon resonance (SPR) technology, a refractive index-based optical biosensor, has significant promise in biomarker detection because of its outstanding features of label-free, sensitivity, and reliability. The nanomaterial features exotic physical and chemical property work on the process of transferring biorecognition event into SPR signal and hence is functioned as signal enhancer. In this review, we mainly discussed the mechanism of gold nanoparticles (AuNPs) and two-dimensional (2D) functional nanomaterial for improving the SPR signal. We also introduced AuNPs and 2D nanomaterial assisted SPR technology in determining cancer biomarker. Last but not least, we discussed the challenges and outlooks of the aforementioned reformative SPR technology for cancer biomarker determination in the clinical trial.
Optical biosensing devices for the affinity analysis of molecular binding events could offer significant advantages over current analytical methods. However, most of those excited with a single optical mode are “blind” to the conformational change of bound molecules. We succeeded in designing Mach-Zehnder interferometers (MZI) with a hybrid plasmonic (HP) waveguide with nano-slots. By addressing the structure with dual polarizations, the optogeometrical properties (density and thickness) of protein layers have been determined without ambiguity. Differences in the hybrid mode dispersion between the transverse electric (TE) and transverse magnetic (TM) modes separately allow the determination of the thickness and the density at all stages during the molecular interaction. Moreover, nano-slots can be equated with an effective optical capacitance resulting in strong field confinement and low propagation loss. A proof of concept is conducted by analyzing the conformational change of HepV, a recombinant fragment of collagen V, during complicated molecular interaction. Instead of wavelength interrogation, a cost-effective method with output intensity variation at particular wavelengths due to “resonance phenomena” was employed to monitor the biological event.
Whispering gallery (WG) mode resonators are experiencing a surge in the application of biosensing, attributing to high speed, flexibility, low cost, multi-analyte detection and compatibility with extra optical elements. The decoration of localized surface plasmon nanostructures to a dielectric WG mode resonator offers unprecedented sensitivity compared with a pure dielectric resonator. However, at the moment, the experimental quality (Q) factors of dielectric micro rings always achieve the value of 104 to 106, whereas the only reported hybrid counterpart possesses the Q factor of 300 and most studies are focused on the theoretical design. The resulting experimental detection limits (DLs) are in the range of 10-6-10-5 RIU, which is one order of magnitude lower than the best value of hybrid resonators. The hybrid resonator should possess the experimental Q factor of 5000 to 10000 so as to match their purely dielectric rivals. We demonstrated a novel hybrid plasmonic WG mode resonator working on the multimode resonance mechanism. Under the condition of the multimode resonance, predominant field was distributed on the waveguide surface resulting in an improved bulk sensitivity. The multimode resonance promoted satisfied resonance frequency reduced and thus a high Q factor and a low value of DL could be achieved in the experiment. Afterwards, the resonator was made via micro- and nano- fabrication. It was shown that the experimental Q factor of 5685 and the free spectral range larger than 35 nm, which were superior to the previously reported value to our best knowledge. Hypoglycemia and Hyperglycemia will produce noticeable organ damage over time. Early detection of glucose concentration is crucial for clinical diagnosis. The proposed resonator was used for the detection of glucose solution. The experimental sensitivity was 428 nm/RIU and the DL was 1.31×10-5 RIU. The device with a footprint of 1500 μm×12.7 μm, is able to integrate with other optical elements and developed as a commodity in the future.
We have designed a multi-analyte biosensing platform based on a hybrid whispering gallery mode resonator to detect protein biomarkers, e.g. those allowing the early diagnosis of Alzheimer’s disease. Our proposed biosensor dependent on the hybrid mode naturally extends the capabilities of both plasmonic sensor and photonic sensor and thus performs better interrogation sensitivity. A multi-resonance of the hybrid mode could occur and the field intensity achieved its maximum value, thereby enabling a very strong light–matter interaction. The detection limit for bulk sensing reached a value of 2 × 10 −5 RIU and that for surface sensing was at 0.6 pg mm −2 . Our novel configuration has an advantage over the conventional plasmonic-waveguide resonator with a similar cavity size ( Q -factor < 500) because a wide range of spectral measurements (56 nm) and a high Q -factor (1300) could be achieved simultaneously. Thus, large refractive index shifts in the medium could be detected with high sensitivity. This biosensor, with a footprint of 625 μ m 2 for each resonator, is a good candidate for integration into lab-on-chip microsystems for large-scale screening of a wide range of protein biomarkers in high risk of developing disease.